Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 787

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 787
---
 share data)

6 . Prepaid Expenses As of December 31, 2023, the amount of prepaid expenses was $ 8,154 , consisting of $ 7,245 of prepaid R&D clinical costs, $ 492 of prepaid insurance and $ 417 of other costs. As of December 31, 2022, the amount of prepaid expenses was $ 16,267 , consisting of $ 15,188 of prepaid R&D clinical costs, $ 543 of prepaid insurance and $ 536 of other costs.

7. Property and Equipment, net

Property and equipment, net consists of the following:

| ​                                              
 ​                                              | ​ 
 ​ 
 ​ | ​            
 December 31, |      ​ 
   2023 | ​ | ​ |      ​ 
   2022 |
|:-----------------------------------------------|:--|:-------------|-------:|:--|:--|-------:|
| Computer and office equipment                  | ​ | $            |    239 | ​ | $ |    239 |
| Furniture and fixtures                         | ​ |              |    596 | ​ |   |    330 |
| Leasehold improvements                         | ​ |              |  4,154 | ​ |   |  1,266 |
| ​                                              | ​ | $            |  4,989 | ​ | $ |  1,835 |
| Less accumulated depreciation and amortization | ​ |              | -1,667 | ​ |   | -1,409 |
| Property and equipment, net                    | ​ | $            |  3,322 | ​ | $ |    426 |

Leasehold improvements include$ 2,533relating to the New Lease entered into in May 2023 that are still in process as of December 31, 2023 and will begin amortization once the improvements are complete. In October and November 2023, the Company determined that$ 1,755of these costs qualified for reimbursement as lease incentives, of which$ 808had been reimbursed to the Company as of December 31, 2023 (see Note 19,Commitments and Contingencies -Lease (New Corporate Headquarters in May 2023).

Depreciation and amortization expense included in R&D expense and G&A expense was$ 259,$ 248and$ 248for the years ended December 31, 2023, 2022 and 2021, respectively.

There werenog